Nucleolin

Results: 8



#Item
1Fostering Nanomedicine Innovation via the EU-NCL  European Nano-Characterisation Laboratory Summary In its propositions to optimise the European Nanomedicine Value Chain and to efficiently support this emerging industria

Fostering Nanomedicine Innovation via the EU-NCL European Nano-Characterisation Laboratory Summary In its propositions to optimise the European Nanomedicine Value Chain and to efficiently support this emerging industria

Add to Reading List

Source URL: www.etp-nanomedicine.eu

Language: English - Date: 2013-06-06 09:30:27
2AML cells carrying NPM1 mutation are resistant to nucleophosmin displacement from nucleoli caused by the G-quadruplex ligand TmPyP4

AML cells carrying NPM1 mutation are resistant to nucleophosmin displacement from nucleoli caused by the G-quadruplex ligand TmPyP4

Add to Reading List

Source URL: www.nature.com

Language: English - Date: 2014-09-25 08:36:04
3Microsoft PowerPoint - New Grodzinski NFAC-rev-I[removed]pptx

Microsoft PowerPoint - New Grodzinski NFAC-rev-I[removed]pptx

Add to Reading List

Source URL: deainfo.nci.nih.gov

Language: English - Date: 2012-02-03 08:53:01
4Volume 1, Issue 1  About the NCL Working in concert with the National Institute of Standards and Technology (NIST) and the U.S. Food and Drug Administration (FDA), the National Cancer Institute (NCI) established the Nano

Volume 1, Issue 1 About the NCL Working in concert with the National Institute of Standards and Technology (NIST) and the U.S. Food and Drug Administration (FDA), the National Cancer Institute (NCI) established the Nano

Add to Reading List

Source URL: ncl.cancer.gov

Language: English - Date: 2007-02-12 14:13:01
5NCL News August 2012 The NCL has Relocated The NCL is now located at the Advanced Technology Research Facility (ATRF) in Frederick, MD. The new state-of-the-art facility will afford NCL the extra space needed to continue

NCL News August 2012 The NCL has Relocated The NCL is now located at the Advanced Technology Research Facility (ATRF) in Frederick, MD. The new state-of-the-art facility will afford NCL the extra space needed to continue

Add to Reading List

Source URL: ncl.cancer.gov

Language: English - Date: 2012-10-16 13:38:28
6Characterization of Nanoparticles Intended for Cancer Therapeutics and Diagnostics

Characterization of Nanoparticles Intended for Cancer Therapeutics and Diagnostics

Add to Reading List

Source URL: www.epa.gov

Language: English - Date: 2006-03-10 15:17:09
7

PDF Document

Add to Reading List

Source URL: eacea.ec.europa.eu

Language: English - Date: 2009-11-19 13:47:46
8

PDF Document

Add to Reading List

Source URL: eacea.ec.europa.eu

Language: English - Date: 2009-11-19 13:47:47